Hypercalcaemia Secondary to Ectopic Parathyroid Hormone Expression in an Adolescent with Metastatic Alveolar Rhabdomyosarcoma
Overview
Oncology
Pediatrics
Affiliations
We report the case of a 14-year-old male with metastatic alveolar rhabdomyosarcoma, presenting with hypercalcaemia (3.89 mmol/l) and elevated parathyroid hormone (PTH) level (10.2 pmol/l). Imaging demonstrated extensive bony lytic damage, with "floating teeth" in the mandible. Normalisation of calcium levels and bony reformation of the mandible occurred following chemotherapy; PTH levels decreased initially but remained above normal levels. Imaging did not demonstrate any evidence of parathyroid abnormality. Tumour ectopic PTH secretion is a very rare cause of hypercalcaemia of malignancy in children. Hypercalcaemia with an elevated PTH, in the absence of parathyroid-related cause, should prompt investigation for underlying malignancy.
Liu H, Gao D, Huang Y, Li J, Zhao M, Lu Z Front Endocrinol (Lausanne). 2023; 14:1125822.
PMID: 36798668 PMC: 9927209. DOI: 10.3389/fendo.2023.1125822.
Malignant Hypercalcemia Due to the Ectopic Production of Calcitriol by an Abdominal Liposarcoma.
Figueiredo A, Pereira T, Cabrera R, Simoes-Pereira J, Leite V Cureus. 2023; 15(1):e33446.
PMID: 36751194 PMC: 9897700. DOI: 10.7759/cureus.33446.
Kim D, Miller A, Li A, Hardy N, Silver K AACE Clin Case Rep. 2021; 7(3):169-173.
PMID: 34095480 PMC: 8165116. DOI: 10.1016/j.aace.2020.11.037.